Welcome to the Zurich Hub for Drug and Device Development (ZH3D)

The Zurich Hub for Drug and Device Development (ZH3D) is a primary center of excellence for drug and device development at the the most prestigious universities and university hospitals in Zurich: the University of Zurich (UZH), the Swiss Federal Institute of Technology Zurich (ETH Zurich), University Hospital Zurich (USZ), University Children’s Hospital Zurich (Kispi), Balgrist University Hospital, and University Hospital of Psychiatry Zurich (PUK).

The conception and development of medicinal products and medical devices by academia is becoming more important. Many researchers now drive the results from basic research forward towards the bedside. However, these promising developments often face a final hurdle: a complex regulatory approval process that can introduce significant non-scientific obstacles. The ZH3D aims to help academic drug and device candidates reach clinical stages more efficiently, quickly, and with the necessary high quality.

The vision of the ZH3D is to serve the academics in Zurich as a primary center of excellence for drug and device development at the UZH and in Switzerland. Already existing GxP services at the UZH/USZ will be bundled and complemented with newly created services. The GxP academy will promote a variety of well-established and new courses at the UZH/USZ and ZH3D supports innovation in the field of drug and device development by providing GxP expertise and quality assurance.